AXPAXLI for Diabetic Retinopathy

Retina Synthesis - A podcast by Retina Synthesis

Categories:

We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.

Visit the podcast's native language site